KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues.
Solassol J, Ramos J, Crapez E, Saifi M, Mangé A, Vianès E, Lamy PJ, Costes V, Maudelonde T
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare KRAS mutation status in FFPE and frozen colorectal tumors. Each specimen was cut into two pieces, 1 of which was snap-frozen in liquid nitrogen and the other was processed for FFPE. DNA was extracted using the QIAamp kit from both types of specimens.
Summary of Findings
DNA yield was similar from FFPE and frozen specimens, but FFPE specimens had higher average cycle threshold (CT) values and a larger range in CT values. Using 33 FFPE specimens with a known KRAS mutation determined using the matched frozen specimen, HRM missclassified 2 (6%) as wildtype, and 2 others did not amplify properly. After sequencing, 6 (18%) FFPE specimens were missclassified as wildtype, and 3 (9.1%) showed mutations not identified using the corresponding frozen specimen. Of the 68 FFPE specimens that did not have a KRAS mutation identified using the matched frozen specimen, all were genotyped as wildtype, but in 4 cases, DNA failed to amplify.
Biospecimens
TissueColorectalPreservation Types
FormalinFrozenDiagnoses
NeoplasticCarcinomaPlatforms
DNASpectrophotometryDNAReal-time qPCRDNADNA sequencingDNASNP assayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation Formalin (buffered)Snap frozenSNP assay Specific Targeted nucleic acid KRASSNP assay Specific Technology platform HRMSequencing